Hemostasis Today

September, 2026
September 2026
M T W T F S S
 123456
78910111213
14151617181920
21222324252627
282930  
ISTH 2026 Highlights, Expert Insights Into Thrombosis and Hemostasis – RFHT
Sep 8, 2026, 15:21

ISTH 2026 Highlights, Expert Insights Into Thrombosis and Hemostasis – RFHT

RFHT (Revue Francophone d’Hémostase et Thrombose), shared a post on LinkedIn:

“The essentials of ISTH 2026 deciphered in interviews

  • How can you go even further with emicizumab? Cedric HERMANS, Liège, Belgium
  • NETs in all their facets: formation, fate and elimination, chloé James, Bordeaux
  • API CAT: what do we know about venous thromboembolic recurrences with apixaban? Isabelle Mahé, Colombes
  • What clinical lessons can be learned from the 3year data from the CASSIOPEIA study on venous thromboembolism? Laurent Frenzel, New York, United States
  • Von Willebrand disease: should the 2B variants be reclassified New York? Melanie Daniel, Lille
  • Endothelial cells: a new role in the mechanisms of thrombosis? David Smadja, Paris
  • Post MTEV patient caregiver communication session: a new tool to improve living better with one’s pathology? Francis Couturaud, Brest
  • Can we still improve the prevention of thrombotic risk? Catherine Lemarie, Brest”

Proceed to the video attached to the post.

ISTH 2026 Highlights, Expert Insights Into Thrombosis and Hemostasis - RFHT

Stay updated with Hemostasis Today.